Skip to main content
OpenTrials

Clinical trial condition

Bulbo-Spinal Atrophy, X-Linked

Explore clinical trials studying Bulbo-Spinal Atrophy, X-Linked. Study availability and eligibility vary by location and protocol.

40 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Bulbo-Spinal Atrophy, X-Linked trial results

Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

NCT07723248

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Urology Specialists of the Carolinas - University Place Charlotte, North Carolina, United States
  • Summit Urology Murray, Utah, United States
View Trial Details
Recruiting

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

NCT06764485

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Local Institution - 0370 Anaheim, California, United States
  • Moores Cancer Center La Jolla, California, United States
View all 281 locations
View Trial Details
Recruiting

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

NCT07336446

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • Research Site Duarte, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 18 locations
View Trial Details
Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07190300

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Uni Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Wichita Urology Group PA Wichita, Kansas, United States
View all 31 locations
View Trial Details
Recruiting

ALS/MND Natural History Study Data Repository

NCT05966038

Conditions
ALS, Amyotrophic Lateral Sclerosis, Bulbar Palsy, Progressive, +21 more
Locations
  • Loma Linda University Health Loma Linda, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 18 locations
View Trial Details
Recruiting

Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy

NCT06862596

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Tokyo University Hospital Bunkyō City, Japan
  • Chiba University Hospital Chiba, Japan
  • Hokkaido University Hospital Sapporo, Japan
  • Jichi Medical University Hospital Shimotsuke, Japan
View Trial Details

Related conditions